• Citer

What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study

par Pizzamiglio, Sara;Cosentino, Giulia;Ciniselli, Chiara Maura;De Cecco, L.;Cataldo, Alessandra;Plantamura, Ilaria;Triulzi, Tiziana;El-abed, Sarra;Wang, Yingbo;Bajji, Mohammed;Nuciforo, Paolo Giovanni;Huober, J.;Ellard, Susan S.L.;Rimm, David D.L.;Gombos, Andrea ;Daidone, Maria Grazia;Verderio, Paolo;Tagliabue, Elda;Di Cosimo, Serena;Iorio, Marilena Valeria
Référence Cancer Medicine
Publication Publié, 2021

Article révisé par les pairs

• Détails
• Contenu

Titre:	What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study
Auteur:	Pizzamiglio, Sara; Cosentino, Giulia; Ciniselli, Chiara Maura; De Cecco, L.; Cataldo, Alessandra; Plantamura, Ilaria; Triulzi, Tiziana; El-abed, Sarra; Wang, Yingbo; Bajji, Mohammed; Nuciforo, Paolo Giovanni; Huober, J.; Ellard, Susan S.L.; Rimm, David D.L.; Gombos, Andrea; Daidone, Maria Grazia; Verderio, Paolo; Tagliabue, Elda; Di Cosimo, Serena; Iorio, Marilena Valeria
Informations sur la publication:	Cancer Medicine
Statut de publication:	Publié, 2021
Sujet CREF:	Généralités
Mots-clés:	biomarkers
	breast cancer
	HER2
	microRNA
	trastuzumab
Note générale:	SCOPUS: ar.j
	DecretOANoAutActif
Langue:	Anglais
Identificateurs:	urn:issn:2045-7634
	info:doi/10.1002/cam4.4449
	info:scp/85121430218